Clinical Trial Update: The Ability of Songha Night ® to Improve Sleep in Patients With Mild to Moderate Sleep Disturbances [Phase 3]

View source ↗

Summary

This entry reports the completion of Boehringer Ingelheim's Phase 3 trial evaluating Songha Night for sleep initiation and maintenance disorders. The trial asse…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Songha Night

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Sleep Initiation and Maintenance Disorders | Phase 3 | Status: COMPLETED